Correction: Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability

Slični predmeti

• Correction: Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability
  od: Valerie Haller, i dr.
  Izdano: (2025-01-01)
• SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation
  od: Liangying Zhang, i dr.
  Izdano: (2025-02-01)
• cKIT Mutations in GISTs and Other Malignancies in Thailand
  od: Thongbliew Prempree, i dr.
  Izdano: (2006-03-01)
• Significance of KIT and PDGFRA mutations in gastric gist imatinib - naive surgically treated patients
  od: Ebrahimi Keramatollah, i dr.
  Izdano: (2019-01-01)
• KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST
  od: Shishan Zhou, i dr.
  Izdano: (2024-02-01)